Cargando…
Targeting the Brain with Single-Domain Antibodies: Greater Potential Than Stated So Far?
Treatments for central nervous system diseases with therapeutic antibodies have been increasingly investigated over the last decades, leading to some approved monoclonal antibodies for brain disease therapies. The detection of biomarkers for diagnosis purposes with non-invasive antibody-based imagin...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916958/ https://www.ncbi.nlm.nih.gov/pubmed/36768953 http://dx.doi.org/10.3390/ijms24032632 |